Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay

• Published in: PloS one Vol. 12; no. 7; p. e0180669
• Main Authors: Lebani, Kebaneilwe, Jones, Martina L, Watterson, Daniel, Ranzoni, Andrea, Traves, Renee J, Young, Paul R, Mahler, Stephen M
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 06.07.2017; Public Library of Science (PLoS)
• Subjects: Animals; Antibodies, Viral - immunology; Antigenic determinants; Antigens; Assaying; Bacteriophages - genetics; Binders; Bioengineering; Biology and Life Sciences; Cercopithecus aethiops; Cloning; Cross-reactivity; Dengue; Dengue fever; Dengue virus; Dengue Virus - immunology; Development and progression; Diagnosis; Diagnostic software; Diagnostic systems; Disease control; Enzyme-Linked Immunosorbent Assay; Epitopes; Fluorescent Antibody Technique; Glycoproteins; Homology; Immunization; Immunoassay; Immunodominance; Immunofluorescence; Immunoglobulins; Immunology; In vitro methods and tests; Infection; Infections; Infectious diseases; Markers; Medicine and Health Sciences; Methods; Microspheres; Monoclonal antibodies; Multiplexing; Nanotechnology; Phage display; Proteins; Quantum dots; Research and Analysis Methods; Resonance; Serotypes; Serotyping; Serotyping - methods; Surface Plasmon Resonance; Training; Tropical diseases; Vector-borne diseases; Vero Cells; Viral diseases; Viral Nonstructural Proteins - immunology; Viremia; Viruses; West Nile virus; Zika virus; Queensland Australia; Australia
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0180669

The multidimensional nature of dengue virus (DENV) infections, which can be caused by four distinct serotypes of the virus, complicates the sensitivity of assays designed for the diagnosis of infection. Different viral markers can be optimally detected at different stages of infection. Of particular clinical importance is the early identification of infection, which is pivotal for disease management and the development of blood screening assays. Non-structural protein 1 (NS1) is an early surrogate marker of infection and its detection in serum coincides with detectable viraemia. The aim of this work was to isolate and characterise serotype-specific monoclonal antibodies that bind to NS1 for each of the four DENV serotypes. This was achieved using phage display and a subtractive biopanning strategy to direct the antibody selection towards serotype-specific epitopes. This antibody isolation strategy has advantages over immunisation techniques where it is difficult to avoid antibody responses to cross-reactive, immunodominant epitopes. Serotype specificity to recombinant antigen for each of the antibodies was confirmed by Enzyme Linked Immunosorbent Assay (ELISA) and Surface Plasmon Resonance. Confirmation of binding to native DENV NS1 was achieved using ELISA and immunofluorescence assay on DENV infected Vero cells. No cross-reactivity with Zika or Kunjin viruses was observed. A previously isolated pan-reactive antibody that binds to an immunodominant epitope was able to pair with each of the serotype-specific antibodies in a sandwich ELISA, indicating that the serotype specific antibodies bind to epitopes which are all spatially distinct from the immunodominant epitope. These antibodies were suitable for use in a multiplexed assay for simultaneous detection and serotyping of DENV NS1 in human serum. This work demonstrates that phage display coupled with novel biopanning strategies is a valuable in vitro methodology for isolation of binders that can discern amongst antigens with high homology for diagnostic applicability.